Johns Hopkins Medicine Hosts Briefing on Women’s Health

Experts address COVID-19, the pandemic’s effects on stress and anxiety, and emerging research related to Alzheimer’s disease
Johns Hopkins Medicine

NOTE: This press release has been republished because the names of two speakers were inadvertently omitted.

Since its inception in 1995, the mission for A Woman’s Journey has remained the same: to empower women to make the right health care decisions for their families and themselves.

WHAT: A Woman’s Journey will host a two hour virtual event during which Johns Hopkins Medicine experts will address important issues related to women’s health and provide vital information regarding medical advances and cutting edge research. Registrants will learn about COVID-19, systemic racism, the effect of the pandemic and social crises on stress and anxiety, emerging research about dementia, “red flag” risks for heart disease that are unique to women, how intermittent fasting impacts brain function, fibroid tumors among Black women and other topics.

WHY: This briefing provides an opportunity to hear from Johns Hopkins Medicine faculty physicians about discoveries and innovations in the prevention, diagnosis and treatment of illnesses that particularly affect women.

WHEN: Saturday, Nov. 7
10 a.m.– noon

WHERE: Virtual event via Zoom

REGISTRATION: Registration fees for journalists will be waived. Contact Waun’Shae Blount at 410-955-3195 or to arrange registration.

WHO: Speakers and topics are as follows. 

Plenary Speaker: Sherita Hill Golden, M.D., M.H.S., event keynote speaker and vice president and chief diversity officer at Johns Hopkins Medicine, will discuss her journey confronting racism and how she is leading efforts to address health disparities and their contributing factors including microaggressions, and systemic and structural racism at Johns Hopkins.

Diagnosing Early Cancer: Anne Marie Lennon, Ph.D., M.B.B.Ch., director of gastroenterology and hepatology and professor of medicine, will discuss potential early warning signs of cancer and reveal details about a groundbreaking diagnostic test that has emerged from Johns Hopkins research.

Blue Zones: Alicia Arbaje, M.D., M.P.H., director of translational care research and associate professor of medicine, will discuss longevity and healthy lifestyles among centenarians living in specific global habitats known as “blue zones” — places around the world where people live longer and healthier lives.

Fibroids Among African Americans: Khara Simpson, M.D., assistant professor of gynecology and obstetrics, will share details about prevalence and disparities regarding fibroids among Black women, early symptoms, risks associated with fibroids and the status of treatments.

Inflammation: Lisa Christopher-Stine, M.D., M.P.H., director of the Johns Hopkins Myositis Center and associate professor of medicine, will highlight chronic inflammation in relation to ailments from cancer, heart disease and arthritis to autoimmune diseases and dementia — and strategies to reduce chronic inflammation’s health impact.

Why Fasting Is Good for Your Brain, and Maybe Your Body: Mark Mattson, Ph.D., will discuss intermittent fasting and its potential metabolic and brain impact.

Hearty Advice: Erin Michos, M.D., M.H.S., director of women’s cardiovascular health and associate professor of medicine, will highlight risks of heart disease in women and effective and ineffective prevention strategies.

Emerging Research About Memory: Marilyn Albert, Ph.D., director of the Johns Hopkins Department of Cognitive Science and professor of neurology, will share research initiatives to delay and treat Alzheimer's disease, as well as information on the relationship between lifestyle factors and dementia risk.

Stress and Anxiety: Erica Richards, M.D., Ph.D., chair and medical director of the Department of Psychiatry and Behavioral Sciences at Sibley Memorial Hospital and assistant professor of psychiatry and behavioral sciences, will discuss ways to mitigate emotional stress while coping with anxiety and worry due to the pandemic and social and political crises. 

An Inflection Point: COVID-19: Lisa Maragakis, M.D., M.P.H., event keynote speaker, Johns Hopkins associate professor of medicine and senior director of infection prevention, will share the latest information about COVID-19 and its persistent threat, and how this transformative experience has influenced Dr. Maragakis’ professional and personal life.

More information about the sessions and featured speakers, and the names of sponsors, can be found here.

To schedule an interview with any of the speakers or to register for the event, please contact Waun’Shae Blount at 410-955-3195 or   

Filters close

Showing results

110 of 4149
Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 11:00 AM EST Released to reporters: 30-Nov-2020 8:40 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Showing results

110 of 4149